What's new with us

Stay updated by reading our latest news

We work hard with cancer clinics, research institutes and life sciences partners to provide each cancer patient with more personalised care. Read more below.

Latest Updates

Kaiku Health and MSD Germany collaborate to develop AI-enabled digital patient monitoring for lung cancer patients

Kaiku Health, the developer of a digital health intervention service in oncology, and MSD Germany, an affiliate of one of the largest pharmaceutical companies in the world, collaborate to develop digital patient monitoring and management for lung cancer patients. Lung cancer is one of the most common cancer types. While it especially affects smokers, lung...

Read the article

The Netherlands Cancer Institute partners with Kaiku Health to develop the next generation of digital patient monitoring and management

The Netherlands Cancer Institute (NKI), an internationally acclaimed Comprehensive Cancer Center, collaborates with Kaiku Health, an innovator in the field of digital therapeutics for oncology, to develop the next generation of patient-reported outcomes and symptom management. The collaboration is part of a larger clinical trial named NADINA, a phase III trial for neoadjuvant immunotherapy for...

Read the article

Kaiku Health achieves 2015 Edition ONC Health IT Certification in the US

Kaiku Health has achieved Office of the National Coordinator for Health Information Technology 2015 Edition Health IT certification in the United States. The stamp of approval designates that Kaiku Health delivers the required functionality in support of enabling eligible providers and hospitals in the US to meet the requirements of various regulatory programs that involve...

Read the article

Kaiku Health, Oulu University Hospital and Vaasa Central Hospital to present research at ESMO Congress 2021

Kaiku Health, together with Oulu University Hospital and Vaasa Central Hospital, presents research at the virtual ESMO Congress 2021. The research investigates how ePRO follow-up affects patient care of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy. According to the results, ePRO follow-up was found to be good with 98% of the patients suggesting that the...

Read the article

Follow us on social platforms

Media contact

Ellen Nurmi
ellen.nurmi@kaikuhealth.com
+358 445512744

Contact

Get in touch with us

Interested in learning more about Kaiku Health? Send us a note